CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $447,000 | -62.3% | 17,827 | -45.2% | 0.12% | -70.4% |
Q4 2021 | $1,185,000 | +278.6% | 32,550 | +543.4% | 0.41% | +112.6% |
Q4 2020 | $313,000 | -33.3% | 5,059 | -40.9% | 0.19% | -45.3% |
Q3 2020 | $469,000 | -1.3% | 8,559 | +3.6% | 0.35% | -41.9% |
Q2 2020 | $475,000 | – | 8,260 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |